YC

Yuhan Corporation

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Yuhan Co, Ltd. is a South Korean pharmaceutical and chemical company.

Investor Profile

Yuhan Corporation has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series C (50%)
  • Seed (50%)

Country Focus

  • South Korea (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Information Technology
  • Medical
  • Artificial Intelligence (Ai)
  • Medical Device
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Yuhan Corporation frequently co-invest with?

AI
Europe, England, United Kingdom, London
Co-Investments: 1
Altos Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Timewise Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
SV
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
KB Securities
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
FuturePlay
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
HUINNO
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Yuhan Corporation?

Huinno Aim

Seongdong, Kyonggi-do, South Korea

Huinno Aim is a clinical decision support system platform that designs wearable device based on AI technology for the medical industry.

Artificial Intelligence (AI)Health CareMedical DeviceSoftware
SeedAug 17, 2022
Amount Raised: $3,041,343
Syntekabio

Daejeon, Taejon-jikhalsi, South Korea

Syntekabio is a public company, listed on the KOSDAQ. It is an AI drug discovery and development company based on genomic big data.

BiotechnologyHealth CareInformation TechnologyMedical
Series CJul 1, 2019
Amount Raised: $16,971,785